Indications and uses
first aid to help prevent infection in minor cuts scrapes burns
first aid to help prevent infection in minor cuts scrapes burns
clean the affected area and dry thoroughly apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily may be covered with a sterile bandage
store at controlled room temperature see carton or tube crimp for lot number and expiration date
Drug Facts
| Active ingredient (each gram contains) | Purpose |
|---|---|
| Bacitracin zinc 400 units | First aid antibiotic |
| Neomycin sulfate 3.5 mg | First aid antibiotic |
| Polymyxin B sulfate 5,000 units | First aid antibiotic |
first aid to help prevent infection in
For external use only
Ask a doctor before use
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
white petrolatum
Distributed by
Albertsons, Inc.
Boise, Idaho 83726
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 204602 | bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment | PSN | 1 |
| 204602 | bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment | SCD | 1 |
| 204602 | bacitracin 400 UNT / neomycin 3.5 MG (as neomycin sulfate 5 MG) / polymyxin B 5000 UNT per GM Topical Ointment | SY | 1 |
| Class | Version | Type | Effective |
|---|---|---|---|
| BACITRACIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NEOMYCIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| POLYMYXIN B Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 99e684e6-f435-feb8-d2bb-3a546f1cb768 | Product name | 2 | 20161117 |
| 25340b3b-3e4c-4ff8-abf6-3e62ec46bd0c | Product name | 1 | 20160603 |
| 2d352c73-a357-4193-a4de-dfdf9a2ac8e4 | Product name | 1 | 20150819 |
| b045ad64-0f28-9a02-2f9b-b34d94fb2278 | Product name | 1 | 20140508 |
| b6082387-f592-1148-0844-bd068fd213fb | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 41163-016-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2f0e-f424-e053-dadaa90a57ce | equaline™ triple antibiotic |
| 41163-016-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2f0e-f424-e053-dadaa90a57ce | equaline™ triple antibiotic |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41163-016-01 | equaline triple antibiotic | 14.2 g in 1 TUBE | OINTMENT | 14.2 | 1 | |
| 41163-016-01 | equaline triple antibiotic | 1 in 1 CARTON | OINTMENT | 1 | 1 | |
| 41163-016-02 | equaline triple antibiotic | 28.4 g in 1 TUBE | OINTMENT | 28.4 | 1 | |
| 41163-016-02 | equaline triple antibiotic | 1 in 1 CARTON | OINTMENT | 1 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Bacitracin zinc | ACTIVE INGREDIENT | 89Y4M234ES | 1 | |
| Neomycin sulfate | ACTIVE INGREDIENT | 057Y626693 | 1 | |
| Polymyxin B sulfate | ACTIVE INGREDIENT | 19371312D4 | 1 | |
| Bacitracin | ACTIVE MOIETY | 58H6RWO52I | 1 | |
| Neomycin | ACTIVE MOIETY | I16QD7X297 | 1 | |
| Polymyxin B | ACTIVE MOIETY | J2VZ07J96K | 1 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 41163-016 | 41163-016-01, 41163-016-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Bacitracin zinc | 89Y4M234ES | ACTIM |
| Neomycin sulfate | 057Y626693 | ACTIM |
| Polymyxin B sulfate | 19371312D4 | ACTIM |
| petrolatum | 4T6H12BN9U | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| petrolatum | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f8f88d9d-723a-4c5f-8000-b81745e994f5 | 55ba9a6d-9dd9-433a-9221-c1075480e226 | 2013-03-06 | Warnings | f8f88d9d-723a-4c5f-8000-b81745e994f5 55ba9a6d-9dd9-433a-9221-c1075480e226 |
Adverse event summaries are temporarily unavailable. Other product information remains available.